Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

BIOENGINEER.ORG
bioengineer.org > gelatin-hydrogel-salbutamol-study-retracted-over-overlapping-microscopy-images

Gelatin Hydrogel Salbutamol Study Retracted Over Overlapping Microscopy

2+ hour, 31+ min ago   (682+ words) A study that promised a new way to deliver the asthma drug salbutamol sulphate through gelatin-based swellable hydrogels has been struck from the scientific record....

pharmabiz.com
pharmabiz.com > NewsDetails.aspx

Adneuris Therapeutics presents novel data on lead candidate, cebranopadol to treat moderate-to-severe acute pain at PAINWeek 2026

1+ day, 15+ hour ago   (249+ words) Monmouth Junction, New Jersey Saturday, Septembe... Adneuris Therapeutics presents novel data on lead candidate, cebranopadol to treat moderate-to-severe acute pain at PAINWeek 2026 Adneuris Therapeutics, a wholly owned subsidiary of Tris Pharma advancing a new kind of pain medicine, announced novel…...

openPR.com
openpr.com > news > 4627274 > global-trends-overview-the-rapid-evolution-of-the-non-opioid

Global Trends Overview: The Rapid Evolution of the Non-Opioid Pain Treatment Market

2+ day, 23+ hour ago   (59+ words) openPR.com Global Trends Overview: The Rapid Evolution of the Non-Opioid Pain Treatment Market Press release from: The Business research company Permanent link to this press release: You can edit or delete your press release Global Trends Overview: The Rapid…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > adneuris-therapeutics-presents-novel-data-on-lead-candidate-cebranopadol-for-the-treatment-of-moderate-to-severe-acute-pain-at-painweek-2026-1036536586

Adneuris Therapeutics Presents Novel Data on Lead Candidate, Cebranopadol for the Treatment of Moderate-to-Severe Acute Pain at PAINWeek 2026

2+ day, 16+ hour ago   (261+ words) Adneuris unveiled new abuse potential data demonstrating that cebranopadol's abuse potential may be lower than that of Schedule II and Schedule IV pain drugs, further differentiating its dual NOP/MOP mechanism from drugs like oxycodone. The Phase 3 ALLEVIATE studies met…...

Tuko.co.ke - Kenya news.
tuko.co.ke > entertainment > celebrities > 639338-natalie-githinji-shares-terrifying-hospital-ordeal-endometriosis-battle

Video: Natalie Githinji shares scary hospital ordeal battling endometriosis

2+ day, 20+ hour ago   (445+ words) NTV presenter Natalie Githinji has opened up about the harrowing experience of undergoing an MRI scan as she continues her recovery from a severe endometriosis flare-up, describing panic attacks, claustrophobia and the kind of discomfort that only fellow patients might…...

openPR.com
openpr.com > news > 4627123 > key-trends-and-emerging-changes-shaping-the-non-opioid-pain

Key Trends and Emerging Changes Shaping the Non-Opioid Pain Patch Market Landscape

3+ day, 2+ hour ago   (59+ words) openPR.com Key Trends and Emerging Changes Shaping the Non-Opioid Pain Patch Market Landscape Press release from: The Business Research Company Permanent link to this press release: You can edit or delete your press release Key Trends and Emerging Changes…...

ZAWYA
zawya.com > en > press-release > companies-news > new-removable-stent-technology-comes-to-dubai-to-treat-severe-below-the-knee-artery-disease-483414

New removable stent technology comes to Dubai to treat severe below-the-knee artery disease

3+ day, 20+ hour ago   (265+ words) Dubai, UAE – Medcare Hospital Al Safa has introduced SPUR® Retrievable Scaffold Therapy, becoming the first hospital in Dubai to use the innovative technology for patients with severely narrowed or blocked arteries below the knee. For patients with advanced circulation problems,…...

The Independent
independent.co.uk > bulletin > news > prenatal-tylenol-paracetamol-acetaminophen-infants-b3047328.html

Girls exposed to Tylenol in womb had 40% smaller ovaries, study finds

3+ day, 15+ hour ago   (0+ words) ...

GigWise
gigwise.com > blue-lotus-flower-the-legal-botanical-people-are-turning-to-as-the-thc-ban-takes-hold

Blue Lotus Flower: The Legal Botanical People Are Turning to as the THC Ban Takes Hold

4+ day, 4+ min ago   (1311+ words) Blue lotus, known botanically as Nymphaea caerulea, is a blue water lily native to the Nile and parts of East Africa. Despite the name, it is not a true lotus. It is a water lily, and that distinction matters when…...

The Straits Times
straitstimes.com > world > europe > tylenol-use-in-pregnancy-may-be-linked-with-uterus-ovary-changes-in-daughters

Tylenol use in pregnancy may be linked with uterus, ovary changes in daughters

4+ day, 1+ hour ago   (591+ words) Published Sep 09, 2026, 12:07 PM Updated Sep 09, 2026, 12:12 PM Sept 9 - Female reproductive organ development may be impacted by a mother's use of Tylenol during pregnancy, according to researchers who emphasize that their study does not prove the pain medicine is to blame and…...